Randomized, Open-Label Study of the Bria-IMT Regimen and Check Point Inhibitor vs Physicians' Choice in Advanced Metastatic Breast Cancer.
NCT06072612 · RECRUITING · Phase 3
We track 1 ClinicalTrials.gov studies led by Briacell Therapeutics Corporation. The portfolio skews toward Phase 3 (1 trials).
1 clinical trials sponsored by Briacell Therapeutics Corporation.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 3 | 1 | 100% |
Briacell Therapeutics Corporation currently sponsors 1 clinical trials tracked on ReadTheTrial. These span Phase 3.
Briacell Therapeutics Corporation conducts research across multiple therapeutic areas. Browse the trial listings for details.
Yes, Briacell Therapeutics Corporation currently has 1 trial that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.